These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2784142

  • 1. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
    Kirnbauer R, Köck A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA.
    J Immunol; 1989 Mar 15; 142(6):1922-8. PubMed ID: 2784142
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G, Gerrard TL, Goldman NG, Pike SE.
    J Immunol; 1988 Jun 15; 140(12):4329-36. PubMed ID: 2836512
    [Abstract] [Full Text] [Related]

  • 3. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines.
    Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trinchieri G, Schwarz T.
    J Immunol; 1994 Dec 15; 153(12):5366-72. PubMed ID: 7527439
    [Abstract] [Full Text] [Related]

  • 4. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA, Uchida A, Köck A, Colot M, Micksche M.
    J Immunol; 1985 Apr 15; 134(4):2477-83. PubMed ID: 3882831
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.
    Walther Z, May LT, Sehgal PB.
    J Immunol; 1988 Feb 01; 140(3):974-7. PubMed ID: 3276786
    [Abstract] [Full Text] [Related]

  • 6. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D, Cohen BB, Steel CM.
    Eur J Immunol; 1990 May 01; 20(5):961-8. PubMed ID: 2113479
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 8. Epidermal cells synthesize a cytokine with interleukin 3-like properties.
    Luger TA, Wirth U, Köck A.
    J Immunol; 1985 Feb 01; 134(2):915-9. PubMed ID: 3917479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
    Coulie PG, Vanhecke A, Van Damme J, Cayphas S, Poupart P, De Wit L, Content J.
    Eur J Immunol; 1987 Oct 01; 17(10):1435-40. PubMed ID: 3500055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.